Nerelimomab

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

Nerelimomab is a mouse-derived monoclonal antibody that targets TNF-alpha. As a TNF inhibitor, it works by blocking tumor necrosis factor (TNF), a protein that drives inflammation. Because it comes from a mouse source, it is considered a murine antibody.